fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Information as important as medication in migraine pain

Written by | 16 Jan 2014

Findings also show that patients report pain relief even when they know they are receiving a placebo.

FDA Highlights: Prophylactic anastrozole reduces breast cancer development by 53 percent among high risk women

Written by | 10 Jan 2014

by Bruce Sylvester – Prophylactic use of the breast cancer drug anastrozole for five years reduced by 53% the development of breast cancer in post-menopausal women at high… read more.

FDA Highlights: Abatacept shows efficacy for Glomerulosclerosis

Written by | 8 Jan 2014

by Bruce Sylvester – Abatacept, an FDA-approved treatment of rheumatoid arthritis could become the first targeted therapy for focal segmental glomerulosclerosis glomerulosclerosis (FSGS), a condition that usually causes… read more.

Change concept of harm reduction in alcohol policy

Written by | 8 Jan 2014

A new policy paper by a University of York academic calls for limits on the influence of the drinks industry in shaping alcohol policy because it has a… read more.

Drug could diminish psychotic symptoms associated with Parkinson’s disease

Written by | 7 Jan 2014

by Bruce Sylvester – An investigative drug could offer the first safe and effective treatment for psychotic symptoms that affect about half of people with Parkinson’s disease, researchers… read more.

Diflunisal shows efficacy in treating Amyloidosis

Written by | 3 Jan 2014

by Bruce Sylvester – Diflunisal, a generic anti-inflammatory drug, appears to reduce neurological decline and preserve quality-of-life in patients with familial transthyretin amyloidosis (ATTR).

Inflammatory on and off switch identified for allergic asthma and COPD

Written by | 24 Dec 2013

New research in The FASEB Journal suggests that two receptors of leukotriene B4, BLT1 and BLT2, actually play opposite roles in inflammation, suggesting new drug targets and strategies… read more.

Exercise can reduce drug-related joint pain in breast cancer patients

Written by | 13 Dec 2013

A study by Dr. Jennifer Ligibel, Dana-Farber Cancer Institute (pictured), shows exercise can reduce drug-related joint pain in breast cancer patients.

Over half of nonsurgical patients in USA are prescribed opioids during hospitalisations

Written by | 6 Dec 2013

by Bruce Sylvester – A new analysis of over 1 million hospital admissions in US hospitals revealed that over half of all nonsurgical patients were prescribed opioids during… read more.

Poster Session at ECC 2013 – Younger patients at high risk

Written by | 2 Dec 2013

Discussion of the abstract by Dr Christopher Lieu, MD, Assistant professor at the University of Colorado.  Younger patients with colorectal cancer that has spread (metastasised) to other parts… read more.

Poster Session at ECC 2013 – Biology of the tumour key to treatment

Written by | 28 Nov 2013

Discussion of the abstract by Dr Zoran Gatalica, Adjunct Professor of Pathology at Creighton University School of Medicine .

ECC 2013 Report: Joint ECCO/BDA Special Session: Accelerating patient access to innovative drugs in Europe

Written by | 27 Nov 2013

by Peter Mas Mollinedo – Improvements in diagnostics and medical treatments mean the number of patients living with cancer is increasing around the world. The World Health Organization… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.